CCHT(SZ:000661)2022-12-08 01:34Group 1: Urban Renewal Project - The urban renewal project in Changchun High-tech Zone is part of the national initiative to revitalize Northeast China and improve living conditions [3] - The project will be funded through long-term low-interest loans from the National Development Bank, with Changchun Gaoxin Real Estate Development Co., Ltd. responsible for implementation [3] - The project is currently in the preliminary stages, with no significant impact on the company's performance expected in the short term [4] Group 2: Company Structure and Strategy - The company focuses on biopharmaceuticals and health industries as its primary direction, with real estate development as a supplementary business [4] - In biopharmaceuticals, the company is actively developing production technology platforms for genetic engineering, biological vaccines, peptide synthesis, and herbal medicines [4] Group 3: Financial Performance and Sales Strategy - Jin Sai Pharmaceutical's third-quarter performance growth is attributed to effective sales policy adjustments, stabilization of powder injection prices, and successful summer marketing activities [5] - The sales strategy for long-acting growth hormone focuses on major hospitals while also expanding into smaller hospitals and clinics in second-tier and grassroots cities [5] - The long-acting growth hormone is a globally innovative product, with promotional measures including expert clinical guidance to enhance product understanding among doctors and patients [5] Group 4: Competitive Pricing - The pricing of follicle-stimulating hormone will be slightly lower than that of imported products, maintaining a competitive price advantage [5]